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Objective: This study investigated gender differences,
depression, and health-related quality of life (QoL) in a cross-
sectional sample of patients with atrial fibrillation (AF).
Methods: This cross-sectional study involved a convenience
sample of AF patients from two tertiary-care clinics in Toronto,
Canada. Ninety-three AF patients completed psychometrically
validated measures of generic QoL and depression. Mediation
analyses evaluated the relationship between gender and QoL
using depression as mediating variable. Results: Relative to
male patients, female patients reported lower physical, but not
mental, QoL. Gender was associated with both depression and0022-3999/06/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
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E-mail address: lephuong@yorku.ca (L. Ong).physical QoL, while depression was correlated with poorer
physical QoL. Path analyses demonstrated that depression
significantly mediated the relationship between gender and
physical QoL. Conclusion: Among AF patients, female patients
report lower physical QoL relative to male patients, and this
relationship may be mediated by self-reported symptoms of
depression. Albeit correlational, the findings underscore the need
to develop a better understanding of the role of depression in
physical QoL, especially when considering the burden of AF
in women.
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Atrial fibrillation (AF), the most common heart rhythm
disturbance, accounts for one third of all patients hospi-
talized for arrhythmia [1–3]. It is associated with consid-
erable morbidity and mortality [1,2,4], as well as with
significant impairments in health-related quality of life
(QoL) in terms of physical, social, emotional, and mental
functioning [5–8]. AF patients report greater QoL impair-
ments relative to patients with congestive heart failure or
myocardial infarction (MI) [5,9]. QoL impairments persisteven in the absence of structural heart disease [7,10], and it
has been found to be unrelated or only weakly correlated
with indices of disease burden, frequency of episodes, illness
duration, functional class, and ventricular function [7,11].
Gender differences in QoL have been demonstrated and
indicate that female patients report worse QoL relative to
male patients [11–15]. Female patients are also more likely
than male patients to report more AF-related complaints,
such as greater frequency and severity of symptoms
[13,15,16]. However, it is unclear whether these discrep-
ancies are a function of differential illness-reporting styles
between genders, divergent illness evaluations, or whether
female patients actually experience more frequent and
severe AF symptoms. The latter seems plausible if female
patients are older and have more severe comorbidities than
male patients. In Paquette et al.’s study [13], female patientsearch 61 (2006) 769–774
L. Ong et al. / Journal of Psychosomatic Research 61 (2006) 769–774770were older and were more likely to have hypertension, but
after these factors had been controlled, female patients still
reported greater impairments in physical health and func-
tional capacity than male patients.
Taken together, available research suggests that (a) the
QoL of AF patients is impaired relative to other cardiac
patient groups; (b) impairments are present, irrespective of
underlying heart disease severity; and (c) female patients
report poorer QoL than male patients. Despite these
associations, little is known of the factors that might explain
the variability in QoL in AF, particularly with respect to
observed gender differences. One set of factors that might
be important to examine is psychological factors. To date,
only one study has examined personality factors (i.e.,
somatization) that contribute to QoL differences between
men and women with AF, yielding positive support for the
role of nondisease variables [13]. Additional research is
needed to identify psychosocial factors that may be
associated with poorer QoL in female patients.
One variable that has emerged as a robust predictor of
QoL is depression. Among patients with coronary artery
disease and congestive heart failure, depression has been
found to be a stronger predictor of poor health status than
measures of disease severity, such as ejection fraction,
stress-induced ischemia, and New York Heart Class [17,18].
The severity of depression has predicted greater symptom
burden, physical limitations, worse overall health, and poor
QoL [17]. Baseline depression scores have also been linked
with QoL 1 year after MI [19,20].
Since prevalence rates for depression are higher among
women [21,22], coupled with associations between depres-
sion and poor QoL, one might speculate whether any gender
differences in QoL in AF are mediated by symptoms of
depression. This study pursued this line of inquiry and
investigated the relationships between gender, depression,
and QoL. It was hypothesized that female patients would
report poorer mental and physical QoL relative to male
patients, and that self-reported symptoms of depression
would be associated with poorer QoL. Furthermore, self-
reported symptoms of depression were proposed to mediate
the association between gender and QoL.Methods
Participants
This cross-sectional study involved a convenience
sample of AF patients from two tertiary care clinics in
Toronto, Canada. The research ethics boards at each site
reviewed and approved the study procedure. The methods
of this study have been reported in detail [23]. In brief,
eligible participants were identified from the medical charts
in each clinic. Patients who provided informed consent
were mailed a questionnaire package that included study
measures. Patients who did not return their questionnaireswithin a 2-week period were given up to two reminder
telephone calls.
Patients who were 18 years of age or older and with a
primary diagnosis of AF were included. Patients with
concurrent heart disease were included, provided that
valvular disease was mild or absent, and ejection fraction
was unimpaired (i.e., Class I or II). Patients who: (a) could
not read or understand English; (b) had cognitive deficits
documented in their medical charts; (c) had a history of
severe psychiatric illness (e.g., schizoaffective disorder,
bipolar disorder, and schizophrenia); (d) had received an
atrial or implantable cardioverter defibrillator; or (e)
acquired AF as a result of cardiac surgery or other medical
conditions (e.g., hyperthyroidism) were excluded.
Clinical characteristics
Information on illness duration, cardiovascular history
(e.g., coronary heart disease, valve disease, and hyper-
tension), ejection fraction, noncardiac medical history
(e.g., diabetes and cancer), cardioversion, and medications
was obtained via medical chart review.
Study questionnaires
University of Toronto Atrial Fibrillation Severity Scale
This 14-item disease-specific scale was locally con-
structed to evaluate patient-perceived arrhythmia burden.
Data on AF episode frequency and duration were derived
from the AF burden subscale, which has an internal
reliability of .94 [11,24]. Scores range from 1 to 10, where
higher scores indicate greater frequency and duration.
Medical Outcomes Study Short-Form 36 Health Survey
(SF-36)
Generic mental and physical QoL was assessed with this
widely used scale, which measures physical functioning,
physical role limitation, bodily pain, general health, vitality,
social functioning, emotional role limitation, and mental
health [25]. Subscales are combined to form two composite
scores: physical component summary (PCS) and mental
component summary (MCS). The PCS evaluates energy
levels and interference to social, occupational, or role
functioning due to physical health status and bodily pain.
The MCS measures positive affect and limitations to social,
occupational, or role functioning due to emotional distress.
The internal reliability values for the PCS and MCS are
reported to be .93 and .88, respectively [26]. Scores range
from 0 to 100, with higher values indicating better
functioning and fewer limitations.
Hospital Anxiety and Depression Scale (HADS)
This 14-item scale is both reliable and valid, and was
developed to screen for the presence and severity of anxiety
and depression in medical settings since it omits somatic
symptoms of depression (e.g., fatigue and appetite changes)
that may lead to false-positive findings in medical patients
Table 2
Clinical characteristics of patients, by gender




Paroxysmal AF (%) 71.88 52.46 .07
Lone AF (%) 43.75 44.26 .96
Coronary artery disease (%) 6.25 14.75 .23
Valvular heart disease (%) 6.25 3.28 .50
Hypertension (%) 46.88 45.90 .93
Warfarin (%) 53.13 70.49 .10
Amiodarone (%) 21.88 19.67 .80
Sotalol (%) 3.13 11.48 .17
h-Blockers (%) 56.25 54.10 .84
Antidepressants (%) 15.63 3.28 .032
Prior cardioversiona (%) 43.75 65.57 .043
a At least one prior cardioversion.
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been reported to be .86 [28]. Ratings are made on a 4-point
Likert scale (e.g., 0=not at all, 3=definitely) and summed to
produce scores between 0 and 21. Higher scores signify
more depressive symptoms. Snaith and Zigmond [29]
suggest that scores z8 indicate possible depression and
that scores z11 indicate probable depression. Recent work
indicates that the cutoff score of 8 provides an ideal balance
between specificity and sensitivity [30].
Data analysis
Univariate relationships were assessed using Welch’s
t test, Pearson’s r, and v2 statistics. To demonstrate
mediation, regression analyses were conducted to establish
that: (a) the independent variable influences both the
dependent variable and the mediator; and (b) the mediator
has an effect on the dependent variable [31]. Mediation is
demonstrated if the independent variable no longer affects
the dependent variable once the mediator is added to the
model [31]. The significance of mediation effect was
assessed using the Sobel test [32].
Data screening was performed as described in Tabachnick
and Fidell [33]. Reflect and square root transformations
corrected the negatively skewed SF-36 MCS and PCS
distributions. A logarithmic transform corrected positively
skewed HADS scores. Demographic and medical variables
met criteria for a confounding variable if they were
univariately related to both the independent variable and the
dependent variable of interest at ab.10. Control variables were
entered at the first step of the multivariate model. Cronbach’s
a was computed for each scale to determine reliability.
Missing data were random (i.e., did not vary with
demographic characteristics or study variables) and were
imputed with mean scores if at least 50% of scale items were
answered [34]. This procedure left six cases with missing
data, which were imputed with stochastic regression [33].Results
Sample characteristics
Of 189 eligible patients, questionnaires were mailed
to 125 patients who provided informed consent. Of these,
99 packages were returned (79% participation rate), andTable 1
Selected demographic characteristics of patients, by gender
Female (n=32) Male (n=61) P
Age (years; meanFS.E.M.) 62.72F2.27 61.44F1.50 .64
Married/cohabiting (%) 65.63 88.52 .008
Postsecondary education (%) 75.00 83.61 .32
Employment (%) 40.63 59.02 .09
Illness duration (years;
meanFS.E.M.)
8.72F1.32 6.79F.69 .206 were excluded due to severe ventricular dysfunction
(n=1), hyperthyroidism (n=1), participant attrition (n=3),
and lack of written English comprehension (n=1). Thus,
93 adults were included in the study (mean age=61.88F
12.04 years). Participants tended to be male (66%) and
fairly highly educated (see Table 1). Fifty-three percent of
the sample was employed at the time of assessment. No
gender differences were found for age [t(58.02)=1.28,
P=.64], education [v2(1)=1.00, P=.32], or employment
status [v2(1)=2.85, P=.09]. More male patients were
married or cohabiting [v2(1)=7.05, P=.008].
The mean illness duration for all participants was
7.45F6.22 years and did not differ by gender [t(48.35)=
1.30, P=.20; see Table 2]. Twenty-one percent reported
having AF episodes more than once per week, 16% had
episodes between once per week and once per month, and
32% had episodes less than once per month. The mean
episode duration was 1 h or less in 25%, several hours in
25%, and 1 day or more in 14%. There were no gender
differences in perceived episode frequency [t(71.01)=.65,
P=.52]; however, female patients reported lengthier epi-
sodes [t(51.92)=3.57, P=.001]. Gender differences on AF
pattern (persistent/permanent vs. paroxysmal) approached
significance [v2(1)=3.27, P=.07]. More male patients had at
least one prior cardioversion [v2(1)=4.11, P=.043]. No
gender differences were found for the presence of any heart
disease [v2(1)=1.74, P=.18], hypertension [v2(1)=0.008,
P=.93], or cardiovascular medications [e.g., warfarin:
v2(1)=2.77, P=.10; amiodarone: v2(1)=0.063, P=.80;
sotalol: v2(1)=1.86, P=.17; h-blockers: v2(1)=0.039,Table 3








Possiblea 4 (12.5) 6 (9.8) 10 (10.8)
Probableb 3 (9.4) 0 (0.0) 3 (3.2)
a Using a cutoff score of z8.
b Using a cutoff score of z11.
Fig. 1. Mediation model relating gender, depression, and physical QoL.
Values represent standardized regression coefficients. The value inside the
square brackets denotes the effect of gender on physical QoL, with
depression as mediator. *Pb.05; ***Pb.001.
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[v2(1)=4.60, P=.032].
Depression
Reliability analyses indicate that Cronbach’s a =.78 for the
HADS depression subscale. Using a cutoff score of 8, most
participants (89%) did not have significant symptoms of
depression (see Table 3 for the prevalence of depression,
by gender). As expected, female patients reported higher
depression scores relative to male patients [t(63.64)=2.58,
P=.012; see Table 4]. Depression was related to lower
physical (r=.58, Pb.001) and mental QoL (r=.51,
Pb.001), but did not vary as a function of age (r=.14,P=.17).
QoL
Cronbach’s a =.85 for both mental and physical QoL,
indicating good reliability. Female patients reported signifi-
cantly lower physical QoL [t(60.70)=2.15, P=.003] relative
to male patients. No gender differences were found on
mental QoL [t(48.04)=1.16, P=.25].
Mediation analysis
Univariate analyses revealed gender differences for
marital status, AF pattern, AF duration, prior cardioversion,
and antidepressant use (all Pb.10). However, none of these
variables was concurrently related to any of the dependent
measures and, thus, did not meet criteria for a confounding
variable (all PN.10). In contrast, employment status [de-
pression: t(85.83)=3.70, Pb.001; physical QoL: t(84.70)=
4.32, Pb.001], prior MI [depression: t(6.79)=2.83,
P=.03; physical QoL: t(5.80)=2.98, P=.03], and non-
cardiac medical history [gender: v2(1)=12.51, Pb.001;
physical QoL: t(80.90)=4.33, Pb.001] were controlled for
in the regression model.
Compared to male patients, female patients had higher
depression scores (b=.26, P=.012) and poorer physical QoL
(b=.22, P=.032). Depression was negatively correlated
with physical QoL (b=.48, Pb.001). When depression was
entered as a mediator into the model, the relationship between
gender and physical QoL was reduced (b=.12, P=.18),
while the relationship between depression and physical QoL
remained significant (b=.44, Pb.001). In addition, the
indirect effect between gender and physical QoL, throughTable 4





Physical QoLa 40.69F1.89 47.73F1.20 .003
Mental QoLa 50.67F1.76 53.48F.81 .25
Depressionb 4.19F.63 2.61F.31 .012
a Higher scores indicate better health-related QoL.
b Higher scores indicate more depressive symptoms.depression, was significant (Sobel z =2.31, P= .021;
R2=.43; see Fig. 1). Taken together, the results suggest that
the relationship between gender and physical QoL may be
mediated by self-reported symptoms of depression.Discussion
This study investigated the nature of gender differences
in QoL in AF patients and explored whether depression
mediated the effects of gender on QoL. In this sample, male
patients’ mental and physical QoL scores are consistent
with age-matched Canadian national normative values for
the SF-36 [35]. Female patients also scored within the
national norm for mental QoL but scored almost 1 S.D.
below the national norm for physical QoL. Gender differ-
ences in physical and mental QoL scores are comparable to
those of a published AF cohort [13].
Approximately 11% of our total sample met criteria for
possible depression, which is slightly lower than the
14.4–14.6% reported by Stordal et al. [36] in their
population study. Their study [36] also suggests that HADS
scores increase with age, although we did not find that
association in our sample. Mean depression scores are
consistent with previous work involving AF patients with
patient-activated atrial defibrillators [37] and post-MI
patients [19,38,39] but were somewhat lower than scores
reported by patients with implantable defibrillators [40].
This latter finding is perhaps not surprising as AF patients
without implanted defibrillators are not faced with the
stressful experience of unpredictable defibrillator shocks.
As hypothesized, AF has a greater impact on self-reported
physical QoL in female patients than in male patients,
despite similarities in age, cardiac history, ejection fraction,
type of AF, AF episode frequency, and cardiac medications.
Thus, it may be that female patients have a style of
responding to or perceiving AF that is correlated with poor
physical QoL outcomes. For instance, women may be more
likely to perceive episodes of fibrillation or symptoms of
their arrhythmia as more distressful, burdensome, or
intrusive than men, which might lead to a greater attunement
or preoccupation with AF symptoms. Previous work is
consistent with this possibility, demonstrating that female
L. Ong et al. / Journal of Psychosomatic Research 61 (2006) 769–774 773patients had a greater tendency than male patients to amplify
their physical symptoms [13], which may lead to heightened
health-related distress. In contrast, no gender differences
were found with respect to perceived mental QoL. This
pattern of findings corroborates with the results of previous
investigations [13,14] that have demonstrated greater impair-
ments in physical functioning, but not in terms of mental
functioning, in female patients relative to male patients.
Self-reported symptoms of depression were found to be
associated with poorer physical and mental QoL. To our
knowledge, this is the first study to show this association in
AF patients, and it is congruent with recent studies linking
depression to poorer physical QoL in coronary artery
disease [17] and post-MI [41]. Recent longitudinal data
also show that depressive symptoms following a cardiac
event contribute to future perceptions of QoL [20]. It is
conceivable that depression might contribute to poorer
mental and physical QoL through related cognitive and
behavioral processes. For instance, depressed mood may
increase perceptions of arrhythmia burden, while anhedonia
may cause patients to behaviorally disengage from daily
activities. Each of these processes may further fuel low
mood and may perpetuate a vicious cycle of depressive
symptoms and poor QoL.
Self-reported depressive symptoms significantly medi-
ated the relationship between gender and physical QoL, and
accounted for 43% of the variance in QoL. Hence, it appears
that the relatively increased susceptibility of female patients
to depressive symptoms might be a major contributing
factor to their poorer perceived physical QoL compared to
male patients. While the mediation model accounted for a
considerable portion of the variance in physical QoL, it is
likely that there are multiple mediating factors and that
depression accounts for just one aspect of the association
between gender and physical QoL. As the mean depression
scores of the sample were lower than published cutoff scores
recommended for probable depression [28], the results
illustrate that even subclinical levels of depression may
adversely affect QoL.
Although our findings provide important insights into
gender differences in the QoL of AF patients, several
limitations must be noted. First, all participants were
recruited from highly specialized tertiary care clinics. These
patients may differ from patients seen in general cardiology
practice along many dimensions such as AF severity,
treatment resistance, and distress factors that may ultimately
affect perceived QoL. It is therefore difficult to determine
whether study findings are applicable to AF patients seen in
community cardiology practice. Second, the results are
based on a convenience sample, which potentially limits the
generalizability of the findings and increases the risk of
selection bias. However, our results are still informative of
the QoL of patients who attend specialty arrhythmia clinics.
Third, the relatively small sample limits the number of
confounding variables that can be considered in the multi-
variable model. Fourth, significantly more male patientstended to be married and more female patients were taking
antidepressants, which might indicate potential selection
bias. However, observed gender differences in marital status
are representative of the general population of Canadians
between the fifth and the seventh decades of life [42].
Similarly, gender differences in antidepressant usage are a
natural reflection of the higher prevalence of depressive
symptoms among female patients [21,43,44]. Finally, the
cross-sectional design of the current study renders it
impossible to establish causal relationships between study
variables. Studies employing a prospective longitudinal
design are needed to elucidate the direction of the relation-
ships between gender, depression, and QoL.Acknowledgments
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